Abstract
As common mental disorders, depression and anxiety impact people all around the world. Recent studies have found that the gut microbiome plays an important role in mental health. It is becoming possible to treat mental disorders by regulating the composition of the gut microbiota. Bacillus licheniformis is a probiotic used to treat gut diseases through balancing the gut microbiome during lasting years. Considering the role of gut microbiota in the gut-brain axis, this study used chronic unpredictable mild stress (CUMS) model rats to explore whether Bacillus licheniformis can prevent and treat depression and anxiety. We found that B. licheniformis reduced the depressive-like and anxiety-like behaviours of the rats during the CUMS process. Meanwhile, B. licheniformis changed the gut microbiota composition; increased the short chain fatty acids (SCFAs) in the colon, decreased kynurenine, norepinephrine, and glutamate levels; and increased the tryptophan, dopamine, epinephrine, and γ-aminobutyric acid (GABA) in the brain. After correlation analysis, we found Parabacteroides, Anaerostipes, Ruminococcus-2, and Blautia showed significant correlation with neurotransmitters and SCFAs, indicating the gut microbiome plays an important role in B. licheniformis reducing depressive-like behaviours. Therefore, this study suggested B. licheniformis may prevent depressive-like and anxiety-like behaviours while regulating the gut microbiota composition and increasing the SCFA levels in the colon to alter the levels of the neurotransmitters in the brain.
Key points
• B. licheniformis reduced depressive-like and anxiety-like behaviours induced by the chronic unpredictable mild stress.
• GABA levels in the brain are assonated with B. licheniformis regulating depressive-like and anxiety-like behaviours.
• Gut microbiota composition alteration followed by metabolic changes may play a role in the GABA levels increase.
Similar content being viewed by others
Data availability
The data that support the findings of this study are openly available in China National Center for Bioinformation/Bei**g Institute of Genomics, Chinese Academy of Sciences (GSA: CRA009266) at https://ngdc.cncb.ac.cn/gsa.
Change history
27 June 2023
A Correction to this paper has been published: https://doi.org/10.1007/s00253-023-12643-9
References
Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdeau E, Fioramonti J, Bueno L, Theodorou V (2012) Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrino 37:1885–1895. https://doi.org/10.1016/j.psyneuen.2012.03.024
Aoki R, Onuki M, Hattori K, Ito M, Yamada T, Kamikado K, Kim YG, Nakamoto N, Kimura I, Clarke JM, Kanai T, Hase K (2021) Commensal microbe-derived acetate suppresses NAFLD/NASH development via hepatic FFAR2 signalling in mice. Microbiome 9:188. https://doi.org/10.1186/s40168-021-01125-7
Bell KJ, Saad S, Tillett BJ, McGuire HM, Bordbar S, Yap YA, Nguyen LT, Wilkins MR, Corley S, Brodie S, Duong S, Wright CJ, Twigg S, de St GB, Harrison LC, Mackay CR, Gurzov EN, Hamilton-Williams EE, Marino E (2022) Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation. Microbiome 10:9. https://doi.org/10.1186/s40168-021-01193-9
Benitez-Paez A, Gomez DPE, Lopez-Almela I, Moya-Perez A, Codoner-Franch P, Sanz Y (2020) Depletion of Blautia species in the microbiota of obese children relates to intestinal inflammation and metabolic phenotype worsening. Msystems 5:e819–e857. https://doi.org/10.1128/mSystems.00857-19
Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:16050–16055. https://doi.org/10.1073/pnas.1102999108
Caballero S, Kim S, Carter RA, Leiner IM, Susac B, Miller L, Kim GJ, Ling L, Pamer EG (2017) Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell Host Microbe 21:592–602. https://doi.org/10.1016/j.chom.2017.04.002
Caso JR, MacDowell KS, Gonzalez-Pinto A, Garcia S, de Diego-Adelino J, Carceller-Sindreu M, Sarramea F, Caballero-Villarraso J, Gracia-Garcia P, De la Camara C, Aguera L, Gomez-Lus ML, Alba C, Rodriguez JM, Leza JC (2021) Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder. Transl Psychiatry 11:645. https://doi.org/10.1038/s41398-021-01755-3
Chang L, Wei Y, Hashimoto K (2022) Brain-gut-microbiota axis in depression: a historical overview and future directions. Brain Res Bull 182:44–56. https://doi.org/10.1016/j.brainresbull.2022.02.004
Chen Y, Lin H, Cole M, Morris A, Martinson J, Mckay H, Mimiaga M, Margolick J, Fitch A, Methe B, Srinivas VR, Peddada S, Rinaldo CR (2021) Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM. Microbiome 9:237. https://doi.org/10.1186/s40168-021-01168-w
Chi L, Khan I, Lin Z, Zhang J, Lee MYS, Leong W, Hsiao WLW, Zheng Y (2020) Fructo-oligosaccharides from Morinda officinalis remodeled gut microbiota and alleviated depression features in a stress rat model. Phytomedicine 67:153–157. https://doi.org/10.1016/j.phymed.2019.153157
Coureuil M, Lécuyer H, Bourdoulous S, Nassif X (2017) A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat Rev Microbiol 15:149–159. https://doi.org/10.1038/nrmicro.2016.178
Cryan JF, O'Riordan KJ, Cowan C, Sandhu KV, Bastiaanssen T, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-Smith CM, Lyte JM, Martin JA, Molinero-Perez A, Moloney G, Morelli E, Morillas E et al (2019) The microbiota-gut-brain axis. Physiol Rev 99:1877–2013. https://doi.org/10.1152/physrev.00018.2018
Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16:461–478. https://doi.org/10.1038/s41575-019-0157-3
Daniela PV, De la Fuente MK, Glauben L, María JG, Rodrigo Q, Gerard D, Hermie JMH, Klaas NF, Marcela AH (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277. https://doi.org/10.3389/fimmu.2019.00277
Das P, Babaei P, Nielsen J (2019) Metagenomic analysis of microbe-mediated vitamin metabolism in the human gut microbiome. BMC Genomics 20:208–211. https://doi.org/10.1186/s12864-019-5591-7
Davari S, Talaei SA, Alaei H, Salami M (2013) Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome-gut-brain axis. Neuroscience 240:287–296. https://doi.org/10.1016/j.neuroscience.2013.02.055
de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O'Sullivan O, Clarke G, Stanton C, Dinan TG, Cryan JF (2018) Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. J Physiol 596:4923–4944. https://doi.org/10.1113/JP276431
Deng B, Wu J, Li X, Men X, Xu Z (2017) Probiotics and probiotic metabolic product improved intestinal function and ameliorated LPS-induced injury in rats. Curr Microbiol 74:1306–1315. https://doi.org/10.1007/s00284-017-1318-7
Dinan TG, Stanton C, Cryan JF (2013) Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74:720–726. https://doi.org/10.1016/j.biopsych.2013.05.001
Du Y, Gao XR, Peng L, Ge JF (2020) Crosstalk between the microbiota-gut-brain axis and depression. Heliyon 6:e4097. https://doi.org/10.1016/j.heliyon.2020.e04097
Duman RS, Sanacora G, Krystal JH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102:75–90. https://doi.org/10.1016/j.neuron.2019.03.013
Egerton S, Donoso F, Fitzgerald P, Gite S, Fouhy F, Whooley J, Dinan TG, Cryan JF, Culloty SC, Ross RP, Stanton C (2022) Investigating the potential of fish oil as a nutraceutical in an animal model of early life stress. Nutr Neurosci 25:356–378. https://doi.org/10.1080/1028415X.2020.1753322
Feng S, Meng C, Hao Z, Liu H (2022) Bacillus licheniformis reshapes the gut microbiota to alleviate the subhealth. Nutrients 14:1642. https://doi.org/10.3390/nu14081642
Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S, Carling D, Swann JR, Gibson G, Viardot A, Morrison D, Louise TE, Bell JD (2014) The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 5:3611. https://doi.org/10.1038/ncomms4611
Gomez-Nguyen A, Basson AR, Dark-Fleury L, Hsu K, Osme A, Menghini P, Pizarro TT, Cominelli F (2021) Parabacteroides distasonis induces depressive-like behavior in a mouse model of Crohn’ s disease. Brain Behav Immun 98:245–250. https://doi.org/10.1016/j.bbi.2021.08.218
Guida F, Turco F, Iannotta M, De Gregorio D, Palumbo I, Sarnelli G, Furiano A, Napolitano F, Boccella S, Luongo L, Mazzitelli M, Usiello A, De Filippis F, Iannotti FA, Piscitelli F, Ercolini D, de Novellis V, Di Marzo V, Cuomo R, Maione S (2018) Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav Immun 67:230–245. https://doi.org/10.1016/j.bbi.2017.09.001
Hao Z, Wang W, Guo R, Liu H (2019) Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic effects on chronic unpredictable mild stress-induced depression-like and anxiety-like behavior in rats. Psychoneuroendocrino 104:132–142. https://doi.org/10.1016/j.psyneuen.2019.02.025
Heo J, Kim SK, Park KS, Jung HK, Kwon JG, Jang BI (2014) A double-blind, randomized, active drug comparative, parallel-group, multi-center clinical study to evaluate the safety and efficacy of probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in patients with diarrhea. Intest Res 12:236. https://doi.org/10.5217/ir.2014.12.3.236
Hjelmsø MH, Hansen LH, Baelum J, Feld L, Holben WE, Jacobsen CS, Löffler FE (2014) High-resolution melt analysis for rapid comparison of bacterial community compositions. Appl Environ Microbiol 80:3568–3575. https://doi.org/10.1128/AEM.03923-13
Huang W, Hu W, Cai L, Zeng G, Fang W, Dai X, Ye Q, Chen X, Zhang J (2021) Acetate supplementation produces antidepressant-like effect via enhanced histone acetylation. J Affect Disord 281:51–60. https://doi.org/10.1016/j.jad.2020.11.121
**g Y, Yu Y, Bai F, Wang L, Yang D, Zhang C, Qin C, Yang M, Zhang D, Zhu Y, Li J, Chen Z (2021) Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis. Microbiome 9:59. https://doi.org/10.1186/s40168-021-01007-y
Johnston CS, Jasbi P, ** Y, Bauer S, Williams S, Fessler SN, Gu H (2021) Daily vinegar ingestion improves depression scores and alters the metabolome in healthy adults: a randomized controlled trial. Nutrients 13:4020. https://doi.org/10.3390/nu13114020
Kelly JR, Allen AP, Temko A, Hutch W, Kennedy PJ, Farid N, Murphy E, Boylan G, Bienenstock J, Cryan JF, Clarke G, Dinan TG (2017) Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 61:50–59. https://doi.org/10.1016/j.bbi.2016.11.018
Keute M, Ruhnau P, Heinze HJ, Zaehle T (2018) Behavioral and electrophysiological evidence for GABAergic modulation through transcutaneous vagus nerve stimulation. Clin Neurophysiol 129:1789–1795. https://doi.org/10.1016/j.clinph.2018.05.026
Knox NC, Forbes JD, Peterson C, Van Domselaar G, Bernstein CN (2019) The gut microbiome in inflammatory bowel disease: lessons learned from other immune-mediated inflammatory diseases. Am J Gastroenterol 114:1051–1070. https://doi.org/10.14309/AJG.0000000000000305
Li Y, Liu M, Zhou J, Hou B, Su X, Liu Z, Yuan J, Li M (2019) Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice. Benef Microbes 10:543–553. https://doi.org/10.3920/BM2018.0122
Liu C, Finegold SM, Song Y, Lawson PA (2008) Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 58:1896–1902. https://doi.org/10.1099/ijs.0.65208-0
Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, Luo CX, Chen H, Zhu DY, Zhou QG (2018) Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 13:1686–1698. https://doi.org/10.1038/s41596-018-0011-z
Liu H, Qin Y, Li K, Li M, Yang J, Tao H, Tang Y, Yang L, Chen S, Liu Y, Yang C, Gao W, Sun T (2021a) Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota. Brit J Pharmacol 178:946–963. https://doi.org/10.1111/bph.15338
Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W (2021b) Blautia—a new functional genus with potential probiotic properties? Gut Microbes 13:1–21. https://doi.org/10.1080/19490976.2021.1875796
Logan AC, Katzman M (2005) Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 64:533–538. https://doi.org/10.1016/j.mehy.2004.08.019
Luu M, Monning H, Visekruna A (2020) Exploring the molecular mechanisms underlying the protective effects of microbial SCFAs on intestinal tolerance and food allergy. Front Immunol 11:1225. https://doi.org/10.3389/fimmu.2020.01225
Machiels K, Sabino J, Vandermosten L, Joossens M, Arijs I, de Bruyn M, Eeckhaut V, Van Assche G, Ferrante M, Verhaegen J, Van Steen K, Van Immerseel F, Huys G, Verbeke K, Wolthuis A, de Buck VOA, D'Hoore A, Rutgeerts P, Vermeire S (2017) Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut 66:79–88. https://doi.org/10.1136/gutjnl-2015-309398
Meng C, Feng S, Hao Z, Dong C, Liu H (2022) Antibiotics exposure attenuates chronic unpredictable mild stress-induced anxiety-like and depression-like behavior. Psychoneuroendocrino 136:105620. https://doi.org/10.1016/j.psyneuen.2021.105620
Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189–200. https://doi.org/10.1080/19490976.2015.1134082
Nie Q, Chen H, Hu J, Tan H, Nie S, **e M (2020) Effects of nondigestible oligosaccharides on obesity. Annu Rev Food Sci Technol 11:205–233. https://doi.org/10.1146/annurev-food-032519-051743
Pu J, Liu Y, Gui S, Tian L, Yu Y, Song X, Zhong X, Chen X, Chen W, Zheng P, Zhang H, Gong X, Liu L, Wu J, Wang H, **e P (2021) Metabolomic changes in animal models of depression: a systematic analysis. Mol Psychiatry 12:7328. https://doi.org/10.1038/s41380-021-01269-w
Qureshi T, Bjørkmo M, Nordengen K, Gundersen V, Utheim TP, Watne LO, Storm-Mathisen J, Hassel B, Chaudhry FA (2020) Slc38a1 conveys astroglia-derived glutamine into GABAergic interneurons for neurotransmitter GABA synthesis. Cells 9:1686. https://doi.org/10.3390/cells9071686
R Core Team (2021) R: A language and environment for statisticalmcomputing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 1:6. https://doi.org/10.1186/1757-4749-1-6
Rognes T, Flouri T, Nichols B, Quince C, Mahé F (2016) VSEARCH: a versatile open source tool for metagenomics. PeerJ 4:e2584. https://doi.org/10.7717/peerj.2584
Rowlands BD, Klugmann M, Rae CD (2017) Acetate metabolism does not reflect astrocytic activity, contributes directly to GABA synthesis, and is increased by silent information regulator 1 activation. J Neurochem 140:903–918. https://doi.org/10.1111/jnc.13916
Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167:915–932. https://doi.org/10.1016/j.cell.2016.10.027
Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI (2007) The human microbiome project. Nature 449:804–810. https://doi.org/10.1038/nature06244
van der Hee B, Wells JM (2021) Microbial regulation of host physiology by short-chain fatty acids. Trends Microbiol 29:700–712. https://doi.org/10.1016/j.tim.2021.02.001
Wong ML, Inserra A, Lewis MD, Mastronardi CA, Leong L, Choo J, Kentish S, **e P, Morrison M, Wesselingh SL, Rogers GB, Licinio J (2016) Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry 21:797–805. https://doi.org/10.1038/mp.2016.46
Wu T (1990) Biologic characteristics of Bacillus lichniformis strain 20386 and its micro-ecologic activities in vitro and in vivo. Chinese. J Ecol 2:1–12. https://doi.org/10.13381/j.cnki.cjm.199002001
Yang HJ, Kwon DY, Kim HJ, Kim MJ, Jung DY, Kang HJ, Kim DS, Kang S, Moon NR, Shin BK, Park S (2015) Fermenting soybeans with Bacillus licheniformis potentiates their capacity to improve cognitive function and glucose homeostaisis in diabetic rats with experimental Alzheimer’s type dementia. Eur J Nutr 54:77–88. https://doi.org/10.1007/s00394-014-0687-y
Yuan X, Chen B, Duan Z, **a Z, Ding Y, Chen T, Liu H, Wang B, Yang B, Wang X, Liu S, Zhou JY, Liu Y, Wang Q, Shen Z, **ao J, Shang H, Liu W, Shi G et al (2021) Depression and anxiety in patients with active ulcerative colitis: crosstalk of gut microbiota, metabolomics and proteomics. Gut Microbes 13:1987779. https://doi.org/10.1080/19490976.2021.1987779
Zou J, Chassaing B, Singh V, Pellizzon M, Ricci M, Fythe MD, Kumar MV, Gewirtz AT (2018) Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring IL-22-mediated colonic health. Cell Host Microbe 23:41–53. https://doi.org/10.1016/j.chom.2017.11.003
Funding
This work was financially supported by the grant from the Bei**g Natural Science Foundation (7222112) and National Natural Science Foundation of China (82101626).
Author information
Authors and Affiliations
Contributions
SF, ZH, and YZ designed the study. ZH supervised the study. SF, CM, and YL performed the experiments. SF, CM, YL, YY, AL, YZ, and ZH performed data analysis. SF, CM, ZH, and YZ wrote the paper. SF, CM, YL, YY, AL, YZ, and ZH contributed to the editing and revision of the paper. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
This study was approved by the Biological and Medical Ethics Committee of Beihang University (Bei**g, China). Animal experiments were performed according to the National Institute of Health Guide for the Care and Use of Laboratory Animals.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original version of this article was revised. The affiliation order is now corrected.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Feng, S., Meng, C., Liu, Y. et al. Bacillus licheniformis prevents and reduces anxiety-like and depression-like behaviours. Appl Microbiol Biotechnol 107, 4355–4368 (2023). https://doi.org/10.1007/s00253-023-12580-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-023-12580-7